Observational analysis improved ondansetron bioavailability in patients, indicating enhanced compliance with fast dissolving strips.
Fast dissolving oral strips provide a more convenient and patient-friendly alternative to conventional oral dosage forms for those patients having difficulty in swallowing tablets/capsules etc. strips uses a water-dispersing polymer to boost the drug's bioavailability as it release straight into the bloodstream without the liver having to digest it first. Administering Ondansetron hydrochloride via fast dissolving strips has a number of benefits, including increased patient compliance and improved therapeutic efficacy due to the drug's quick absorption from the highly vascularized oral mucosa, which prevents first-pass metabolism. The antiemetic medication Ondansetron, an antagonist for serotonin receptor type 5 (SERT5), is useful in managing nausea and vomiting brought on by chemotherapy for cancer. Only 60–70% of its limited oral bioavailability may be attributed to first-pass metabolism. Ondansetron has a half-life of three to five hours and is readily soluble in water, making this route of administration appropriate. The goal of this study is to formulate Ondansetron as fast dissolving oral strip intended for instant release in an effort to maximize its therapeutic impact.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: